New Brunswick's chief medical officer of health Dr. Jennifer Russell announced on Thursday that the province is pausing the use of the AstraZeneca COVID-19 vaccine for first doses, but will be accepting 13,500 doses of AstraZeneca next week and will be using it for second doses.

During a news briefing Thursday afternoon, Russell said two additional cases of vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), the rare blood clotting disorder connected with AstraZeneca, have been confirmed in the province — for a total of four cases.

Russell says discussions are ongoing at the national level about mixing vaccine brands.

New Brunswick is reporting 16 new cases of COVID-19, one of which involves someone isolating outside of the province.

For more info, please go to [ Ссылка ]

Subscribe to Global News Channel HERE: [ Ссылка ]
Like Global News on Facebook HERE: [ Ссылка ]
Follow Global News on Twitter HERE: [ Ссылка ]
Follow Global News on Instagram HERE: [ Ссылка ]
#GlobalNews

свернуть